Ghazal Ahmad
Neurology · Augusta, GANPI 1366019622
Payments from drug & device makers
Across 77 payments — averaging $37.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$683
- AbbVie$598
- Jazz Pharmaceuticals Inc.$244
- AstraZeneca$235
- SK Life Science, Inc.$164
- Teva Pharmaceuticals USA, Inc.$138
- plus $799 from 19 others
What the payments were for
- Food & beverage$2,861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 23 | $683 |
| AbbVie | 9 | $598 |
| Jazz Pharmaceuticals Inc. | 7 | $244 |
| AstraZeneca | 6 | $235 |
| SK Life Science, Inc. | 6 | $164 |
| Teva Pharmaceuticals USA, Inc. | 2 | $138 |
| Novartis | 3 | $131 |
| CSL Behring | 1 | $113 |
| TG Therapeutics, Inc. | 1 | $112 |
| Biogen | 2 | $54 |
| Amgen | 2 | $52 |
| Livanova USA, Inc. | 2 | $36 |
| Argenx US, Inc. | 1 | $33 |
| Neurelis, Inc. | 1 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| EMD Serono, Inc. | 1 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| ITF Therapeutics LLC | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Biocodex, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Sanofi | 1 | $17 |
| Pfizer | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,861 in reported general payments places this provider in the 55th percentile of 506 neurology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 17 | $724 |
Paid to pharmacies, not to this prescriber.
Other neurology in Augusta
- John MorganAugusta$1.3M
- Alexis ShaeferAugusta$279K
- Askiel BrunoAugusta$275K
- Jerry PruittAugusta$121K
- Bryan HoAugusta$97K
- Debra Moore-HillAugusta$88K
- Kapil SethiAugusta$55K
- Jonathan LissColumbus$25M
- Marshall NashDecatur$13.6M
- James LahAtlanta$6.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.